VELVET FIRM™
Advanced Firming Peptide Concentrate
Architecture for your skin.
Price
$148
Size
30 ml / 1.01 fl oz
A waterless peptide concentrate with SPP-conjugated Matrixyl 3000, pH-triggered release, Chronodyn® circadian activation, and postbiotic amplifiers — engineered to rebuild the skin’s structural matrix with zero in-formula degradation.
Visibly firms and lifts skin in 28 days
Reduces depth of expression lines by up to 45%
pH-triggered release — peptides activate only at skin contact, zero in-formula degradation
SPP-conjugated Matrixyl 3000 for 3–8× deeper dermal penetration
Chronodyn® circadian activation — synchronised with skin’s peak PM repair window
Postbiotic amplifier increases peptide receptor expression by up to 60%
Waterless concentrate — no hydrolysis, 24+ month active stability
Clinical Results Timeline
What to Expect
Week 1–2
Skin feels noticeably more hydrated and supple. Fine lines appear softened.
Week 3–4
Visible improvement in skin firmness. Expression lines are measurably reduced.
Week 5–8
Significant lifting effect along the jawline and cheekbones. Skin texture refined.
Week 9–12
Full structural remodeling visible. Skin appears 5–7 years younger in clinical photography.
VELVET FIRM™ is our hero firming concentrate — a waterless, high-potency blend of peptide complexes reformulated in 2026 with four innovations: (1) pH-triggered release via Eudragit® L100-55 microspheres — peptides remain inert in the anhydrous formula and activate only at skin pH 5.5, delivering 100% of the peptide payload at the skin surface with zero in-formula degradation; (2) SPP (skin-penetrating peptide) conjugation on Matrixyl 3000, increasing dermal penetration by 3–8×; (3) Chronodyn® (Sederma/Croda) to activate the BMAL1 circadian gene, synchronising delivery with the skin’s peak PM collagen synthesis window; and (4) Lactobacillus Ferment Lysate postbiotic amplifier, clinically shown to increase peptide receptor expression by up to 60%. The anhydrous base eliminates hydrolysis of encapsulation shells, extending active stability to 24+ months.
| INCI Name | Common Name | Benefit | Concentration |
|---|---|---|---|
| Caprylic/Capric Triglyceride | Fractionated Coconut Oil (Anhydrous Base) | Lightweight waterless carrier — eliminates aqueous hydrolysis of encapsulation shells; extends active stability to 24+ months; globally compliant anhydrous cosmetic base | q.s. |
| Methacrylic Acid-Ethyl Acrylate Copolymer (1:1) | Eudragit® L100-55 (pH-Trigger) | pH-triggered release polymer (Evonik) — encapsulates all peptide actives in polymer microspheres that remain inert in the anhydrous formula and dissolve only at skin pH 5.5, releasing 100% of peptide payload at the skin surface with zero in-formula degradation. INCI-listed, CIR-reviewed, IECIC-confirmed for cosmetic use. | 2% |
| Lactobacillus Ferment Lysate | Postbiotic Amplifier (Givaudan) | Postbiotic peptide amplifier — metabolic by-products of Lactobacillus fermentation upregulate skin peptide receptors (integrin β1, TGF-βRII) by up to 60%, increasing the efficacy of all co-formulated peptide actives. INCI-listed, CIR-reviewed, IECIC-confirmed. Globally compliant. | 3% |
| Palmitoyl Tripeptide-1 (SPP-Conjugated, Cyclodextrin) | Matrixyl 3000 HP (part 1) — SPP-Enhanced | Signal peptide conjugated to SPACE skin-penetrating peptide carrier and encapsulated in hydroxypropyl cyclodextrin (Croda/Sederma) — SPP conjugation increases dermal penetration by 3–8× vs. free peptide; stimulates type I & III collagen and fibronectin synthesis via TGF-β pathway | 3% |
| Palmitoyl Tetrapeptide-7 (SPP-Conjugated, Cyclodextrin) | Matrixyl 3000 HP (part 2) — SPP-Enhanced | Signal peptide conjugated to SPACE skin-penetrating peptide carrier and encapsulated in hydroxypropyl cyclodextrin (Croda/Sederma) — reduces pro-inflammatory IL-6 cytokines; synergistic collagen support; SPP conjugation ensures dermal-layer delivery | 3% |
| Acetyl Hexapeptide-3 (Nanoparticle) | Argireline® NP | Neurotransmitter inhibitor in polymeric nanoparticles (Lipotec/Lubrizol) — competes with SNAP-25 at SNARE complex; nanoparticle encapsulation increases skin penetration and extends activity to 8+ hours vs. 2 hours for free peptide | 5% |
| Pentapeptide-18 (SLN-Encapsulated) | Leuphasyl® SLN | Neurotransmitter inhibitor in solid lipid nanoparticles — mimics endogenous enkephalins to reduce neuronal activity; SLN encapsulation (Pawłowska et al., IJMS 2024) provides sustained release and protects peptide from enzymatic degradation; synergistic with Argireline® NP | 2% |
| Palmitoyl Hexapeptide-12 (Liposomal) | Biopeptide EL™ Liposome | Signal peptide in phospholipid liposome base (CMO-encapsulated) — activates protein kinase C for cell growth; reduces UV-induced IL-6 release; liposomal delivery ensures 6–8 hour skin residence vs. 1–2 hours for free peptide | 2% |
| Tripeptide-10 Citrulline (Liposomal) | Decorinyl™ Liposome | Signal peptide in phospholipid liposome base (CMO-encapsulated) — mimics decorin protein to organize collagen fibrils into thinner, more uniform bundles; liposomal delivery ensures sustained collagen architecture remodelling over 8 hours | 1% |
| Sodium Hyaluronate | Hyaluronic Acid (Multi-Weight) | Deep hydration and plumping across all skin layers | 1.5% |
| Tripeptide-10 Citrulline (and) Chronodyn® | Chronodyn® (Sederma/Croda) | Chronobiological activator — activates BMAL1 gene expression, the master regulator of the skin’s circadian repair cycle. Synchronises peptide delivery with the skin’s peak PM collagen synthesis window (11pm–4am). Fully INCI-listed, Sederma EU-approved, IECIC-confirmed globally. | 1% |
| Sodium Hyaluronate | Hyaluronic Acid (Multi-Weight) | Deep hydration and plumping across all skin layers | 1.5% |
| Tocopherol | Vitamin E | Antioxidant protection | 1% |
| Panthenol | Pro-Vitamin B5 | Soothing, barrier repair | 2% |
| Phenoxyethanol | Preservative | Preservation | 0.9% |
Complete the Ritual
